A director at Boston Scientific Corp sold/sold after exercising options 14,010 shares at 89.269USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...
Ichor Holdings, Ltd. (ICHR) is the dominant player in a critical memory chip subindustry, and it is improving profitability coming out of a difficult two-year period for the industry. Uniform Accounting highlights that the market is missing the company's improving fundamentals, creating an opportunity for equity upside. Ichor is the biggest and highest quality fluid and gas delivery system manufacturer, a key supplier to the growing memory chip market. Difficult supply dynamics in the memory ma...
Boston Scientific (BSX) currently trades near corporate but below historical averages relative to Uniform earnings, with a 25.5x Uniform P/E (Fwd. V/E'). At these levels, markets are pricing in expectations for Uniform ROA to remain stable at 27% levels, accompanied by 5% Uniform asset growth. Meanwhile, analysts expect Uniform ROA to improve to 29% in 2023, accompanied by 3% Uniform asset growth. If sustained going forward, these levels would imply a stock price closer to $44, representing a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.